Anatol J Cardiol. 2017; 17(3): 202-209 | DOI: 10.14744/AnatolJCardiol.2016.7307 | |||
Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort studyServet Altay1, Hüseyin Altuğ Çakmak2, Tuğba Kemaloğlu Öz3, Fatma Özpamuk Karadeniz3, Ayça Türer5, Hatice Betül Erer3, Gülen Feyzan Kılıç4, İbrahim Keleş6, Günay Can7, Mehmet Eren31Department of Cardiology, Faculty of Medicine, Trakya University; Edirne-Turkey2Department of Cardiology, Mustafa Kemalpaşa State Hospital; Bursa-Turkey 3Department of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital; İstanbul-Turkey 4Department of Biochemistry, Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital; İstanbul-Turkey 5Department of Cardiology, Faculty of Medicine, Yeditepe University; İstanbul-Turkey 6Department of Cardiology, Cerrahpaşa Faculty of Medicine, İstanbul University, İstanbul; Ankara-Turkey 7Department of Public Health, Cerrahpaşa Faculty of Medicine, İstanbul University, İstanbul; Ankara-Turkey Objective: A predictive role of serum Pentraxin 3 (PTX3) for short-term adverse cardiovascular events including mortality in acute myocardial infarction (AMI) was reported in recent studies. The aim of the study was to investigate long-term prognostic significance of serum PTX3 in an AMI with 5-year follow-up period in this study. Servet Altay, Hüseyin Altuğ Çakmak, Tuğba Kemaloğlu Öz, Fatma Özpamuk Karadeniz, Ayça Türer, Hatice Betül Erer, Gülen Feyzan Kılıç, İbrahim Keleş, Günay Can, Mehmet Eren. Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study. Anatol J Cardiol. 2017; 17(3): 202-209 Corresponding Author: Servet Altay, Türkiye |
|